JC

James Caruso

President, Chief Executive Officer and Director

Cellectar Biosciences

Cellectar Biosciences Pipeline

DrugIndicationPhase
Iopofosine I 131 (CLR 131)Relapsed/Refractory Multiple MyelomaPhase 3